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The "time of retirement" must be faced by most of us. Invited to join those who
compose your "Festschrift" I wanted much to be among them, but my own long
retirement leaves me without anything to say that is modern and scientifically new
about your science. Therefore, I decided to write a simple letter to recall a few ofthe
many things you have dealt with and with them some thoughts about yourselfthat I
always have in mind. Having done this, it appeared to me suddenly that such a letter
may be considered perhaps as a form of the introductory remarks which I had been
asked to make.
Much time has passed since our paths first crossed. I find that I have a letter from
you dated 1948, in Washington; it describes your feeling about Elsinore Castle
which you had just visited and which we had discussed. This seems an odd beginning
for a long friendship based often on virologic and epidemiologic concerns. But I
believe we had met earlier, probably at some meeting, where you had been sum-
moned for information on the existing state ofinvestigations on infectious hepatitis.
You will remember that you were interested in this disease and were appointed in
1949 director ofthe Hepatitis Virus Laboratory at Yale. A great deal ofinformation
you had to deal with, I know, since later I heard about it from John Paul, whose
reports were reviewed by the Commission on Virus and Rickettsial Diseases. Here
were some ofthe early beginnings ofthe study ofthe agents ofhepatitis, progressing
slowly but carefully then, and only recently blooming in recognition of the agents
and ways of control.
You had other interests, though, at this time. Dr. Paul's long concern with
poliomyelitis was active when you first came to Yale, and you became attracted for a
long and fruitful period to the study of this illness. In this you probably were in-
fluenced by the basic philosophy of the department which, as you have written, was
conceived by Dr. Paul who viewed the disease in living people as "clinical"
epidemiology-a new science involving the circumstances, whether functional or
organic, under which the disease is prone to develop. In this concept emphasis was
placed on the question of "why" as well as "how" the disease emerges under certain
circumstances. You joined in the work on poliomyelitis in 1942 and began studies,
some of which lasted for years. Many dealt with the isolation ofthe virus from man
and its behavior in monkeys. However, there was in addition an infinite array ofim-
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All rights of reproduction in any form reserved.munologic testing which resulted in better understanding of epidemics and, even-
tually, in work supporting the use of live vaccine.
In this large area I shall mention but one of the contributions you made. It was the
demonstration that in poliomyelitis viremia occurred. The excitement which all of us
felt in our laboratory, when you and Dr. McCollum reported your findings, comes
to me quite sharply even now, and to think about it is rejuvenating. Here, previous
ideas which had not been clearly established were refuted. The theory that
poliomyelitis was strictly neurotropic was shown to be erroneous, since you
demonstrated it in the blood of contacts and of nonparalytic cases. The widely held
feeling that the virus grew solely in nerve cells had to be set aside. Obviously, the
disease behaved like many viral infections. You proved that the viremia might be
present early after infection. The question of pathogenesis was thus reopened, and
even now, one might think, still remains for complete solution. Your results gave
promise of the possibility that small amounts of antibody might be effective in
preventing involvement of the nervous system. This suggestion was then of especial
importance, since our friend, William Hammon, was planning a trial of the preven-
tive effect of human gamma globulin, and your findings gave much support for con-
tinuing this trial.
In general, with respect to viremia, everyone was relieved to find that polio-
myelitis was not an exceptionally bizarre disease, but similar to others. Yet, as things
now stand, the fine details of the pathogenesis must still be solved for those who
wish to know, and, in this regard, your findings still left continuing problems which
must at some time be resolved. It is good to know that molecular chemists are now
looking at the intracellular conditions involved in cellular destruction. Guided by the
words of your presidential lecture to the Infectious Disease Society in 1974, the solu-
tion may finally be offered by the "dreamer virologists" who were classified by your
former colleague, Christopher Andrews, as the molecular and genetic virologists. In
contrast, he recognized those whose approaches to disease in the past has been more
medical and epidemiological as "steamer virologists." It is true that lately the
dreamers have become concerned with problems in virulence and pathogenicity
which seem to give new clues, and so now the distinction is not so clear. But it still
exists, and I believe you would say that you had belonged among "the steamers." Yet
I cannot entirely agree with this, since your perception and execution have been ac-
companied by the precision and direction that so impress us with "the dreamers." I
think you have been a good "hybrid" of the two approaches.
After your work on poliomyelitis, you looked at problems arising from the
development of vaccination against rubella and showed that the transmission of the
virus was less in vaccinated persons. Here again the attention of "steamers" on
susceptibility was nicely demonstrated, and the fear of the spread of the vaccine
virus was diminished.
You have, as an epidemiologist, been a great traveler. Always these trips have
been made quietly, the data quickly collected and soon reported. Your capacity to
enter in with the people involved and to obtain the essential information has been
striking to me. The many strange places you visited and the way you obtained infor-
mation have been extraordinary.
I shall not forget the description you gave me of your trip to Russia searching for
evidence that the live poliomyelitis vaccine was being carefully investigated. I still
marvel at the way you managed under conditions that, to me, an execrable traveler,
would have been entirely impossible. In imagination I can still see you picking up
data in an unusual city like Tashkent.
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Through all stages of your actions your associates have admired you. In part they
have been held by your great practical sense, your industry, and your judgment. An
outstanding characteristic of yours is a flair for setting peoples' minds in a mood of
hopeful expectation that things will turn out well. One is basically certain, therefore,
that your future will be happy; that new dreams will come and be effective as they
have been in the past.
The words of a very ancient authority testify to this and to your life's doing:
Dreams are hard, and hard to be discerned; nor are all things therein fulfilled
for men. Twain are the gates of shadowy dreams, the one is fashioned of
horn and one ofivory. Such dreams as pass through the portals of sawn ivory
are deceitful and bear tidings that are unfulfilled. But the dreams that come
forth through the gates of polished horn bring a true issue, whosoever of
mortals beholds them.
The Odyssey, Book 19